Bayesian Estimation of Pharmacokinetic and Pharmacodynamic Parameters in a Mode‐of‐Action‐Based Cancer Risk Assessment for Chloroform
暂无分享,去创建一个
Harvey J Clewell | Melvin E Andersen | Yu-Mei Tan | Kai H Liao | Rory B Conolly | M. Andersen | H. Clewell | R. Conolly | S. Borghoff | M. Gargas | Y. Tan | K. Liao | Michael L Gargas | Susan J Borghoff
[1] Harvey J Clewell,et al. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. , 2006, Regulatory toxicology and pharmacology : RTP.
[2] Fredrik U. Jönsson,et al. Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. , 2001, Toxicology.
[3] J. Laskey,et al. The Metabolic Rate Constants and Specific Activity of Human and Rat Hepatic Cytochrome P-450 2E1 Toward Toluene and Chloroform , 2004, Journal of toxicology and environmental health. Part A.
[4] Brian A. Wong,et al. A 90-day chloroform inhalation study in F-344 rats: profile of toxicity and relevance to cancer studies. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[5] M. Rubin,et al. Maturation of renal function in childhood; clearance studies. , 1949, The Journal of clinical investigation.
[6] I. Ijiri,et al. A statistical analysis of the internal organ weights of normal Japanese people. , 1997, Health physics.
[7] Bradley P. Carlin,et al. BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..
[8] Harvey J Clewell,et al. Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene , 2005, Critical reviews in toxicology.
[9] G. Johanson,et al. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach. , 2002, Toxicology and applied pharmacology.
[10] Yu-Mei Tan,et al. Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[11] G. Johanson,et al. A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane. , 2001, Toxicology and applied pharmacology.
[12] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[13] A. Gelman,et al. Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .
[14] Harvey J Clewell,et al. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. , 2006, Regulatory toxicology and pharmacology : RTP.
[15] Brian J. Smith,et al. BAYESIAN OUTPUT ANALYSIS PROGRAM (BOA) VERSION 1.1 USER'S MANUAL , 2003 .
[16] Frédéric Y. Bois,et al. Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects , 2001, Archives of Toxicology.
[17] F. Guengerich,et al. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. , 1991, Chemical research in toxicology.
[18] Tammie R. Covington,et al. Evaluation of the Potential Impact of Age- and Gender-Specific Lung Morphology and Ventilation Rate on the Dosimetry of Vapors , 2003, Inhalation toxicology.
[19] C. Wolf,et al. Evidence that the androgen receptor mediates sexual differentiation of mouse renal cytochrome P450 expression. , 1991, The Biochemical journal.
[20] M E Andersen,et al. Development of a physiologically based pharmacokinetic model for chloroform. , 1990, Toxicology and applied pharmacology.
[21] F Y Bois,et al. Statistical issues in toxicokinetic modeling: a bayesian perspective. , 2000, Environmental health perspectives.
[22] H J Clewell,et al. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.
[23] Harvey J Clewell,et al. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. , 2002, Regulatory toxicology and pharmacology : RTP.
[24] D. Wolf,et al. Patterns of chloroform-induced regenerative cell proliferation in BDF1 mice correlate with organ specificity and dose-response of tumor formation. , 1998, Carcinogenesis.
[25] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[26] J. Gearhart,et al. In vivo metabolism of chloroform in B6C3F1 mice determined by the method of gas uptake: the effects of body temperature on tissue partition coefficients and metabolism. , 1993, Toxicology and applied pharmacology.
[27] F Y Bois,et al. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[28] Sylvia Richardson,et al. Inference and monitoring convergence , 1995 .
[29] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[30] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.
[31] Andrew Gelman,et al. General methods for monitoring convergence of iterative simulations , 1998 .
[32] D. Wolf,et al. Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice , 1993 .
[33] Melvin E. Andersen,et al. Applying Mode-of-Action and Pharmacokinetic Considerations in Contemporary Cancer Risk Assessments: An Example with Trichloroethylene , 2004 .
[34] F Y Bois,et al. Analysis of PBPK Models for Risk Characterization , 1999, Annals of the New York Academy of Sciences.
[35] C. Wolf,et al. Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes. , 1990, The Biochemical journal.
[36] H. Arito,et al. Carcinogenicity and Chronic Toxicity in Rats and Mice Exposed to Chloroform by Inhalation , 2002 .
[37] Don R. Maszle,et al. MCSim: A Monte Carlo Simulation Program , 1997 .